期刊文献+

大剂量化疗并自体骨髓移植治疗小细胞肺癌

下载PDF
导出
摘要 80年代以来,采用综合措施治疗小细胞肺癌(SCIC)取得了令人瞩目的成就,与未治疗病人相比,中位生存时间延长了4~5倍。尽管如此,完全缓解(CR)在限局型(LD)患者也只有50~60%,广泛型(ED)仅15~20%,中位生存时间分别为12~16个月和7~11个月。
作者 高和 纪树国
出处 《空军总医院学报》 1992年第1期32-34,共3页 Journal of General Hospital of Air Force,PLA
  • 相关文献

参考文献3

  • 1David Cunningham,Stephen W. Banham,Andrew H. Hutcheon,Alistair Dorward,Salim Ahmedzai,Patrick Tansey,Mike Soukop,Robin D. Stevenson,Brian R. Stack,Stanley B. Kaye,Norman Lucie,Alan K. Burnett. High-dose cyclophosphamide and VP 16 as late dosage intensification therapy for small cell carcinoma of lung[J] 1985,Cancer Chemotherapy and Pharmacology(3):303~306
  • 2I. E. Smith,B. D. Evans,S. J. Harland,B. A. Robinson,J. R. Yarnold,J. G. Glees,H. T. Ford. High-dose cyclophosphamide with autologous bone marrow rescue after conventional chemotherapy in the treatment of small cell lung carcinoma[J] 1985,Cancer Chemotherapy and Pharmacology(2):120~124
  • 3Robert L. Souhami,Peter G. Harper,David Linch,Colin Trask,Anthony H. Goldstone,Jeffrey S. Tobias,Stephen G. Spiro,Duncan M. Geddes,John D. M. Richards. High-dose cyclophosphamide with autologous marrow transplantation for small cell carcinoma of the bronchus[J] 1983,Cancer Chemotherapy and Pharmacology(3):205~207

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部